Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Smoking Cessation 1Neoplasms 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 4Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Temozolomide 2Paclitaxel 2Ipilimumab 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Carboplatin 2temsirolimus 1sugemalimab 1semaglutide 1sacituzumab govitecan 1prednylidene 1pirtobrutinib 1paricalcitol 1pamiparib 1olaparib 1mirdametinib 1gadobutrol 1fludarabine phosphate 1fludarabine 1erdafitinib 1enfortumab vedotin 1dupilumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1daratumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Behavior Therapy × 30 days × Clear all
NCT01098955 2026-05-22

Smoking Cessation Treatment for Head & Neck Cancer Patients

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
51 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡